Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2381-2021Class II

EL-Anti-SARS-CoV-2 IgM Kit, Catalog #104-129, IVD. Submitted as EUA202129

Theratest Laboratories, Inc. / initiated 2020-07-30 / Terminated

Thera Test Laboratories, Inc. began a recall of EL-Anti-SARS-CoV-2 IgM Kit, Catalog #104-129, IVD. Submitted as EUA202129 on . FDA classified it as Class II and gives the reason as "Device did not meet the updated EUA packet requirements for positive percent agreement, thus, not adequately validated. Submitted as EUA202129". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-2381-2021
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Theratest Laboratories, Inc.
Product
EL-Anti-SARS-CoV-2 IgM Kit, Catalog #104-129, IVD. Submitted as EUA202129
Product code
QKO Reagent, Coronavirus Serological
Reason for recall
Device did not meet the updated EUA packet requirements for positive percent agreement, thus, not adequately validated. Submitted as EUA202129
FDA root cause
No Marketing Application
Action
An undated letter was issued to their customers attached to an email dated 7/30/2020 explaining the reason for recall and requesting the customer stop testing with the kit.
Quantity in commerce
11 kits
Distribution
US Nationwide distribution in the states of CA, FL, IL, IN, NC, and TX.
Product codes and lots
Kit lot numbers 05204350, exp. 05/01/2021; 05204367, exp. 05/19/2021; and 06204432, exp. 05/19/2021.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2381-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2381-2021Class IITerminatedVoluntary: Firm initiated